European Society of Cardiology quality indicators for the prevention and management of cancer therapy-related cardiovascular toxicity in cancer treatment.
Date
2022-12-13ICR Author
Author
Lee, GA
Aktaa, S
Baker, E
Gale, CP
Yaseen, IF
Gulati, G
Asteggiano, R
Szmit, S
Cohen-Solal, A
Abdin, A
Jurczak, W
Garrido Lopez, P
Sverdlov, AL
Tocchetti, CG
Barac, A
Parrini, I
Zamorano, P
Iakobishvili, Z
Pudil, R
Badimon, L
Kirby, AM
Blaes, AH
Farmakis, D
Curigliano, G
Stephens, R
Lyon, AR
Lopez-Fernandez, T
Type
Journal Article
Metadata
Show full item recordAbstract
AIMS: To develop quality indicators (QIs) for the evaluation of the prevention and management of cancer therapy-related cardiovascular toxicity. METHODS AND RESULTS: We followed the European Society of Cardiology (ESC) methodology for QI development which comprises (i) identifying the key domains of care for the prevention and management of cancer therapy-related cardiovascular toxicity in patients on cancer treatment, (ii) performing a systematic review of the literature to develop candidate QIs, and (iii) selecting of the final set of QIs using a modified Delphi process. Work was undertaken in parallel with the writing of the 2022 ESC Guidelines on Cardio-Oncology and in collaboration with the European Haematology Association, the European Society for Therapeutic Radiology and Oncology and the International Cardio-Oncology Society. In total, 5 main and 9 secondary QIs were selected across five domains of care: (i) Structural framework, (ii) Baseline cardiovascular risk assessment, (iii) Cancer therapy related cardiovascular toxicity, (iv) Predictors of outcomes, and (v) Monitoring of cardiovascular complications during cancer therapy. CONCLUSION: We present the ESC Cardio-Oncology QIs with their development process and provide an overview of the scientific rationale for their selection. These indicators are aimed at quantifying and improving the adherence to guideline-recommended clinical practice and improving patient outcomes.
Collections
Subject
Assessment
Cancer therapy-related cardiovascular toxicity
Cardio-oncology
Outcomes
Quality indicators
Treatment
Humans
Quality Indicators, Health Care
Cardiology
Medical Oncology
Neoplasms
Language
eng
Date accepted
2022-10-21
License start date
2022-12-13
Citation
European Heart Journal - Quality of Care and Clinical Outcomes, 2022, 9 (1), pp. 1 - 7
Publisher
Oxford University Press (OUP)